Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

@article{Thiemann2000LackOB,
  title={Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.},
  author={David R. Thiemann and Josef Coresh and Steven P. Schulman and Gary Gerstenblith and William J Oetgen and Neil R. Powe},
  journal={Circulation},
  year={2000},
  volume={101 19},
  pages={2239-46}
}
BACKGROUND The benefit of intravenous thrombolytic therapy in elderly patients with myocardial infarction is uncertain. There are no randomized trials of thrombolytic efficacy or observational studies of clinical effectiveness that focus specifically on the elderly. METHODS AND RESULTS To determine whether thrombolytic therapy for elderly patients is associated with a survival advantage in a large observational database, we conducted a retrospective cohort study of 7864 Medicare fee-for… CONTINUE READING